Jeanmarie Guenot – Paving The Way For More Effective Cancer Therapies

Jeanmarie Guenot currently serves as the President and CEO of Amphivena Therapeutics Inc, a biotechnology research firm formed in 2013. According to takeda.com, Dr. Guenot has an extensive experience of more than twenty years in biotechnology and pharmaceutical sector and aims to use her experience efficiently in helping Amphivena grow and scale new heights of success in the biotech space. She has done her Masters in Business Administration from The Wharton School of Business and completed her Ph.D. at the University of California.

In her career spanning over two decades, Jeanmarie Guenot has worked with some companies and start-ups. She is also a leading business consultant and has extensive experience in helping with building business strategies that promote business growth and development in the most competitive business sectors or industries. Jeanmarie, before joining Amphivena Therapuetics Inc started her firm named SKS Ocular. It was a startup company that aimed at finding treatment therapies for ocular inflammation, glaucoma, and macular degeneration.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

In the past, Dr. Jeanmarie Guenot has also worked as a business advisor for a reputed firm, Hoffman-La Roche in Shanghai and Basel. She has even served as the Vice President of Business and Corporate Development at PDL Bio-Pharmaceuticals. At PDL BioPharma, Jeanmarie was responsible for managing commercial product portfolios, supervise research and development, mergers and acquisitions, licensing, and overall alliance management for company’s research programs and other business activities on Crunchbase.com. Over the years, Dr. Guenot has accumulated vast experience in project, Alliance and portfolio management experience in diverse sectors, including cardiovascular diseases, ophthalmic diseases, neurology, oncology, autoimmune diseases, and more.

Jeanmarie Guenot has received various awards, which includes Deal of Distinction Award in 2006 by Licensing Executive Society and Innovative Bio-Partnering Award by BioBusiness Network in 2005. Along with being part of the Amphivena Therapeutics, Jeanmarie is also affiliated with Harpoon Therapeutics Inc and also one of the co-founders of biotechnology startup, Maverick Therapeutics Inc.

Jeanmarie Guenot firmly believes that research and development happening in the world of biotechnology would certainly find the cure for cancer one day. And, with her engagement with Amphivena Therapeutics Inc, and other biotechnology firms, she aims to make her contributions.

For more information about Jeanmarie Guenot just visit https://www.linkedin.com/in/jeanmarie-guenot-4a140617.

Leave a Reply

Your email address will not be published. Required fields are marked *